Commitment to Action

TB Vaccine Field Sites and Professional Development Programs

Commitment by

Aeras Global TB Vaccine Foundation

Aeras commits to bring promising new TB vaccine candidates into Clinical Trials by opening new field sites in high burden countries, while concomitantly investing in the public health infrastructure and human capacity in these countries.

Share

Tabs

Overview
Summary

Commitment

TB Vaccine Field Sites and Professional Development Programs

Launched

2006

Est. Duration

5 years

Estimated Total Value

$10,000,000

Region

Asia, Africa

Countries

CAMBODIA, KENYA, MOZAMBIQUE, SOUTH AFRICA

Commitment by

Aeras Global TB Vaccine Foundation

Partner(s) of the Commitment Maker(s)

GlaxoSmithKline PLC, Statens Serum Institut, Kingdom of Denmark, Crucell, Centers for Disease Control and Prevention, Bill & Melinda Gates Foundation